Results 101 to 110 of about 62,191 (215)

Expert consensus on oral management in autoimmune bullous diseases, erythema multiforme and SJS/TEN

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
This international Delphi study achieved expert consensus on 58 statements guiding the management of oral involvement in autoimmune bullous diseases, erythema multiforme and SJS‐TEN. The recommendations emphasize multidisciplinary care, oral hygiene and tailored topical, systemic and inpatient oral management.
Shalini Nayee   +39 more
wiley   +1 more source

Algorithms in Allergy: Treatment of Hypereosinophilic Syndromes, 2026 Update

open access: yes
Allergy, EarlyView.
Guillaume Lefèvre   +5 more
wiley   +1 more source

Treatment strategies for interstitial granulomatous dermatitis: Systematic review and expert opinion

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
Systematic review of 108 studies with a total of 182 patients with interstitial granulomatous dermatitis (IGD). IGD was frequently associated with systemic conditions or drug exposure. Management includes careful medication review and prompt withdrawal of potential triggers. Corticosteroids (systemic and topical) were commonly effective, while biologic
Francesco Bellinato   +4 more
wiley   +1 more source

Paraneoplastic Retinopathy

open access: yes, 1977
Man with oat cell carcinoma of the lung with paraneoplastic retinopathy. Narrowed arterioles. Note absence of obvious retinal pigmentary degeneration.
William F. Hoyt, MD
core  

Non-Progressive CRMP-5 Associated Paraneoplastic Retinopathy

open access: yes, 2022
Paraneoplastic retinitis typically presents with gradual painless visual loss and photosensitivity. Autoimmunity against recoverin is known to cause paraneoplastic retinitis whereas collapsin response mediator protein (CRMP-5), a 62-kDa protein that ...
Isabella Canut; Lindsay Chapman
core  

Algorithms in Allergy: Diagnosis of Hypereosinophilic Syndromes, 2026 Update

open access: yes
Allergy, EarlyView.
Guillaume Lefèvre   +5 more
wiley   +1 more source

Targeted therapies in pemphigus vulgaris: Emerging horizons beyond rituximab

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
Rituximab‐refractory pemphigus vulgaris is driven by B‐cell repopulation, plasma‐cell persistence, IgG4 autoantibodies and anti‐drug antibodies. This review evaluates five emerging targeted classes acting at successive steps of disease: next‐generation anti‐CD20 antibodies, DSG3‐CAAR T cells, BTK inhibitors, BAFF/APRIL inhibitors and FcRn antagonists ...
Rhea Ahuja, Dedee Murrell
wiley   +1 more source

Paraneoplastic syndromes in childhood neuroblastoma [PDF]

open access: yes
INTRODUCTION: Neuroblastoma is a malignant tumor primarily affecting infants. Originating from embryonic cells of the sympathetic nervous system, NB commonly arises in the adrenal glands, followed by the abdomen, mediastinum, head, and neck.
Karłowicz, Konrad   +10 more
core   +3 more sources

Paraneoplastic Syndromes.

open access: yes, 2009
Paraneoplastic syndromes can be defined as a whole of systemic signs and symptoms related to cancer. These signs and symptoms are directly related to substances that the tumor produces or to a host’s reaction to the cancer.
Mario Scartozzi   +3 more
core  

Erythroderma and paraneoplastic dermatoses [PDF]

open access: yes, 2017
Erythroderma is characterised by generalized erythema and infiltration of the skin most often with exfoliation. It is a rare disease with many different causes.
Sigurdsson, V.
core  

Home - About - Disclaimer - Privacy